http://www.reportlinker.com/p0118042/Therapeutics-and-Diagnostics-for-Womens-Disorders.html
Advertisement
This Report:
CHAPTER ONE: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
METHODOLOGY
Advertisement
RELATED BCC STUDIES
ANALYSTS CREDENTIALS
BCC RESEARCH ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY TABLE U.S. MARKET FOR NEW THERAPEUTICS AND DIAGNOSTICS FOR WOMEN'S DISORDERS BY SEGMENT, THROUGH 2013 ($ MILLIONS)
SUMMARY FIGURE U.S. MARKET FORECAST FOR NEW THERAPEUTICS AND DIAGNOSTICS FOR WOMEN'S DISORDERS BY SEGMENT, 2006-2013 ($ MILLIONS)
CHAPTER THREE: INDUSTRY OVERVIEW
DEFINITION OF WOMEN'S DISORDERS
IMPORTANCE OF THE INDUSTRY AND DEMOGRAPHICS
TABLE 1 ESTIMATES OF ANTICIPATED U.S. LIFE EXPECTANCY AT BIRTH AND PROJECTIONS BY GENDER, 2000-2020 (YEARS)
FIGURE 1 ESTIMATES OF ANTICIPATED U.S. LIFE EXPECTANCY AT BIRTH AND PROJECTIONS BY GENDER, 2000-2020 (YEARS)
TABLE 2 PROJECTED GLOBAL FEMALE POPULATION BY AGE, THROUGH 2030 (MILLIONS)
FIGURE 2 PROJECTED GLOBAL FEMALE POPULATION BY AGE, THROUGH 2030 (MILLIONS)
TABLE 3 PROJECTED UNITED STATES FEMALE POPULATION BY AGE, THROUGH 2030 (MILLIONS)
FIGURE 3 PROJECTED UNITED STATES FEMALE POPULATION BY AGE, 2000-2030 (MILLIONS)
HISTORY OF THE INDUSTRY AND RESPONSE TO WOMEN'S HEALTHCARE NEEDS
REGULATORY ENVIRONMENT
EFFECTS OF AGING
FIGURE 4 FEMALE LIKELIHOOD OF GETTING PREGNANT VERSUS INFERTILITY AS AGE PROGRESSES, 2008 (%)
CONTRACEPTIVE INSURANCE COVERAGE
TABLE 4 INSURANCE COVERAGE OF CONTRACEPTIVES BY STATE
CONTRACEPTIVE USE IN TEENS INCREASES
NEW USE FOR CONTRACEPTIVES
AGING AND INFERTILITY
CONTRACEPTIVE PATCH LINKED TO DEATHS
WOMEN AND SEXUAL HEALTH
INCIDENCE OF SEXUAL DYSFUNCTION
VASCULAR TREATMENTS AND SEXUAL DYSFUNCTION
DIAGNOSTICS
NEW DEVELOPMENTS IN SEXUAL DYSFUNCTION TREATMENTS FOR WOMEN
Alista
TABLE 5 U.S. SEXUAL DYSFUNCTION PRODUCTS FOR WOMEN IN DEVELOPMENT, 2008
SEXUAL DYSFUNCTION IN CANCER
INFERTILITY AND CANCER
CHEMOTHERAPY
RADIATION
PREVENTION STRATEGIES
MARKETING AND WOMEN
COUNTERFEIT PHARMACEUTICALS
GENERIC PARTICIPATION
TABLE 6 U.S. PRESCRIPTION GENERIC DRUG APPROVALS FOR CONTRACEPTION BY COMPANY AND APPROVAL DATE, 2003-2008
INTERNATIONAL ISSUES
CHAPTER FOUR: AUTOIMMUNE DISEASES
U.S. MARKET OVERVIEW
MARKET SIZE
TABLE 7 U.S. MARKET FORECAST FOR AUTOIMMUNE DISEASES BY PRODUCT SEGMENT, THROUGH 2013 ($ MILLIONS)
COMPETITIVE ANALYSIS
TABLE 8 MANUFACTURERS OF AUTOIMMUNE DISEASE PRODUCTS, 2008
TABLE 9 U.S. SUMMARY OF AUTOIMMUNE DISEASE MARKET BY COMPETITOR REVENUES, 2008 ($ MILLIONS)
FIGURE 5 U.S. SUMMARY OF AUTOIMMUNE DISEASE MARKET BY COMPETITOR REVENUES, 2008 (%)
MARKET BY DISEASE TYPE
CHRONIC FATIGUE SYNDROME
Incidence and Mortality
Market Indicators
FIBROMYALGIA
Incidence
Diagnostics
Pain in 11 of 18 Tender Point Sites on Digital Palpation
Market Indicators
Current Market Participants
MYASTHENIA GRAVIS
Incidence and Mortality
Diagnostics
Market Indicators
Current Market Participants
SJOGREN'S SYNDROME
Incidence and Mortality
Diagnostics
To order this report:
http://www.reportlinker.com/p0118042/Therapeutics-and-Diagnostics-for-Womens-Disorders.html
More market research reports here!
-- Covers a wide variety of products and disorders that predominantly affect women including autoimmune diseases, women's cancer, gynecological infections and diseases, reproductive-related therapies and diagnostics, rheumatoid arthritis and osteoporosis -- Includes U.S. market forecasts for therapeutics and diagnostics for women's disorders through 2014 -- Provides detailed information based on product categories and their use -- Discusses new therapeutics and diagnostics that have emerged and have a significant impact on women's health -- Profiles leading companies.
SOURCE Reportlinker
